QQQ   269.91 (-0.57%)
AAPL   450.87 (+1.44%)
MSFT   207.07 (-2.55%)
FB   262.58 (-2.19%)
GOOGL   1,493.16 (-0.35%)
AMZN   3,141.93 (-0.81%)
NVDA   449.16 (+0.26%)
CGC   18.02 (+8.36%)
BABA   248.36 (-1.48%)
TSLA   1,424.00 (-1.98%)
MU   49.38 (+1.29%)
GE   6.67 (+4.22%)
AMD   82.62 (-2.63%)
T   30.15 (+0.43%)
F   7.09 (+3.35%)
ACB   10.24 (-0.29%)
GILD   68.32 (-1.49%)
NFLX   484.63 (-2.04%)
DIS   129.14 (-0.61%)
BAC   26.60 (+1.88%)
BA   177.93 (+4.65%)
QQQ   269.91 (-0.57%)
AAPL   450.87 (+1.44%)
MSFT   207.07 (-2.55%)
FB   262.58 (-2.19%)
GOOGL   1,493.16 (-0.35%)
AMZN   3,141.93 (-0.81%)
NVDA   449.16 (+0.26%)
CGC   18.02 (+8.36%)
BABA   248.36 (-1.48%)
TSLA   1,424.00 (-1.98%)
MU   49.38 (+1.29%)
GE   6.67 (+4.22%)
AMD   82.62 (-2.63%)
T   30.15 (+0.43%)
F   7.09 (+3.35%)
ACB   10.24 (-0.29%)
GILD   68.32 (-1.49%)
NFLX   484.63 (-2.04%)
DIS   129.14 (-0.61%)
BAC   26.60 (+1.88%)
BA   177.93 (+4.65%)
QQQ   269.91 (-0.57%)
AAPL   450.87 (+1.44%)
MSFT   207.07 (-2.55%)
FB   262.58 (-2.19%)
GOOGL   1,493.16 (-0.35%)
AMZN   3,141.93 (-0.81%)
NVDA   449.16 (+0.26%)
CGC   18.02 (+8.36%)
BABA   248.36 (-1.48%)
TSLA   1,424.00 (-1.98%)
MU   49.38 (+1.29%)
GE   6.67 (+4.22%)
AMD   82.62 (-2.63%)
T   30.15 (+0.43%)
F   7.09 (+3.35%)
ACB   10.24 (-0.29%)
GILD   68.32 (-1.49%)
NFLX   484.63 (-2.04%)
DIS   129.14 (-0.61%)
BAC   26.60 (+1.88%)
BA   177.93 (+4.65%)
QQQ   269.91 (-0.57%)
AAPL   450.87 (+1.44%)
MSFT   207.07 (-2.55%)
FB   262.58 (-2.19%)
GOOGL   1,493.16 (-0.35%)
AMZN   3,141.93 (-0.81%)
NVDA   449.16 (+0.26%)
CGC   18.02 (+8.36%)
BABA   248.36 (-1.48%)
TSLA   1,424.00 (-1.98%)
MU   49.38 (+1.29%)
GE   6.67 (+4.22%)
AMD   82.62 (-2.63%)
T   30.15 (+0.43%)
F   7.09 (+3.35%)
ACB   10.24 (-0.29%)
GILD   68.32 (-1.49%)
NFLX   484.63 (-2.04%)
DIS   129.14 (-0.61%)
BAC   26.60 (+1.88%)
BA   177.93 (+4.65%)
Log in

NYSE:MRKMerck & Co., Inc. News Headlines

$80.76
-0.26 (-0.32 %)
(As of 08/10/2020 02:46 PM ET)
Add
Compare
Today's Range
$80.30
Now: $80.76
$81.21
50-Day Range
$75.19
MA: $78.33
$82.54
52-Week Range
$65.25
Now: $80.76
$92.64
Volume274,526 shs
Average Volume8.09 million shs
Market Capitalization$204.26 billion
P/E Ratio19.70
Dividend Yield3.01%
Beta0.48

Headlines

Merck & Co., Inc. (NYSE MRK) News Headlines

Source:
DateHeadline
Merck & Co., Inc. (NYSE:MRK) Given "Hold" Rating at Royal Bank of CanadaMerck & Co., Inc. (NYSE:MRK) Given "Hold" Rating at Royal Bank of Canada
marketbeat.com - August 4 at 9:26 AM
Good Time to Get in on Earnings-Winner Merck (NYSE: MRK)  (MRK)Good Time to Get in on Earnings-Winner Merck (NYSE: MRK) (MRK)
marketbeat.com - August 3 at 2:09 PM
Top 4 Dividend Growth Stocks for 2020 (MRK)Top 4 Dividend Growth Stocks for 2020 (MRK)
marketbeat.com - August 3 at 2:08 PM
Pharmaceutical Stocks - Best Pharmaceutical Stocks to Buy (MRK)Pharmaceutical Stocks - Best Pharmaceutical Stocks to Buy (MRK)
marketbeat.com - August 3 at 2:08 PM
Goya CEO, praising Trump, sparks online culture clashGoya CEO, praising Trump, sparks online culture clash
marketbeat.com - July 10 at 10:21 AM
Zacks: Analysts Anticipate Merck & Co., Inc. (NYSE:MRK) Will Announce Quarterly Sales of $12.00 BillionZacks: Analysts Anticipate Merck & Co., Inc. (NYSE:MRK) Will Announce Quarterly Sales of $12.00 Billion
americanbankingnews.com - August 9 at 8:47 PM
Merck & Co., Inc. (NYSE:MRK) Given Consensus Recommendation of "Buy" by AnalystsMerck & Co., Inc. (NYSE:MRK) Given Consensus Recommendation of "Buy" by Analysts
americanbankingnews.com - August 8 at 3:49 PM
 Analysts Expect Merck & Co., Inc. (NYSE:MRK) Will Post Earnings of $1.39 Per Share Analysts Expect Merck & Co., Inc. (NYSE:MRK) Will Post Earnings of $1.39 Per Share
americanbankingnews.com - August 7 at 6:48 PM
Early Sales of Eli Lilly's Migraine Drug DisappointEarly Sales of Eli Lilly's Migraine Drug Disappoint
finance.yahoo.com - August 6 at 2:01 PM
Merck & Co., Inc. (NYSE:MRK) to Post FY2020 Earnings of $5.63 Per Share, Cantor Fitzgerald ForecastsMerck & Co., Inc. (NYSE:MRK) to Post FY2020 Earnings of $5.63 Per Share, Cantor Fitzgerald Forecasts
americanbankingnews.com - August 6 at 7:04 AM
Merck, Hanmi Seal Licence Deal For Fatty Liver Disease TherapyMerck, Hanmi Seal Licence Deal For Fatty Liver Disease Therapy
finance.yahoo.com - August 4 at 3:28 PM
Merck and Hanmi Pharmaceutical Enter into Licensing Agreement to Develop Efinopegdutide, an Investigational Once-Weekly Therapy for Nonalcoholic Steatohepatitis (NASH)Merck and Hanmi Pharmaceutical Enter into Licensing Agreement to Develop Efinopegdutide, an Investigational Once-Weekly Therapy for Nonalcoholic Steatohepatitis (NASH)
finance.yahoo.com - August 4 at 10:28 AM
Goldman Upgrades Merck To Buy, Lifts PTGoldman Upgrades Merck To Buy, Lifts PT
finance.yahoo.com - August 4 at 10:28 AM
Merck & Co., Inc. (NYSE:MRK) Given Hold Rating at Royal Bank of CanadaMerck & Co., Inc. (NYSE:MRK) Given Hold Rating at Royal Bank of Canada
americanbankingnews.com - August 4 at 9:23 AM
Company News for Aug 3, 2020Company News for Aug 3, 2020
finance.yahoo.com - August 3 at 1:44 PM
Merck & Co., Inc. (NYSE:MRK) Upgraded by Goldman Sachs Group to "Buy"Merck & Co., Inc. (NYSE:MRK) Upgraded by Goldman Sachs Group to "Buy"
www.americanbankingnews.com - August 3 at 10:36 AM
Merck & Co. (MRK) Q2 2020 Earnings Call TranscriptMerck & Co. (MRK) Q2 2020 Earnings Call Transcript
finance.yahoo.com - August 1 at 4:19 AM
Merck & Co., Inc.s (MRK) Buy Rating Reiterated at MizuhoMerck & Co., Inc.'s (MRK) Buy Rating Reiterated at Mizuho
www.americanbankingnews.com - July 31 at 11:28 PM
Merck & Co., Inc. (NYSE:MRK) Shares Gap Up  on Better-Than-Expected EarningsMerck & Co., Inc. (NYSE:MRK) Shares Gap Up on Better-Than-Expected Earnings
www.americanbankingnews.com - July 31 at 7:02 PM
Caterpillar sales fall in Q2, Merck raises 2020 outlookCaterpillar sales fall in Q2, Merck raises 2020 outlook
finance.yahoo.com - July 31 at 1:06 PM
Merck (MRK) Beats on Q2 Earnings, Misses Sales, Ups ViewMerck (MRK) Beats on Q2 Earnings, Misses Sales, Ups View
finance.yahoo.com - July 31 at 1:06 PM
Merck's Q2 Sales Got Clobbered by COVID-19, but Still Beat EstimatesMerck's Q2 Sales Got Clobbered by COVID-19, but Still Beat Estimates
finance.yahoo.com - July 31 at 1:06 PM
Merck & Co., Inc. 2020 Q2 - Results - Earnings Call PresentationMerck & Co., Inc. 2020 Q2 - Results - Earnings Call Presentation
seekingalpha.com - July 31 at 10:07 AM
Hemorrhagic Fever Vaccine Market Insights and Global Outlook During 2020 to 2025; Green Cross, IAVI, Merck & Co. Inc.(NYSE:MRK)Hemorrhagic Fever Vaccine Market Insights and Global Outlook During 2020 to 2025; Green Cross, IAVI, Merck & Co. Inc.(NYSE:MRK)
www.marketwatch.com - July 31 at 8:05 AM
Merck & Co., Inc. (MRK)Merck & Co., Inc. (MRK)
au.finance.yahoo.com - July 30 at 10:03 PM
Merck & Co's Earnings OutlookMerck & Co's Earnings Outlook
finance.yahoo.com - July 30 at 5:03 PM
Johnson & Johnson stock outperforms market on strong trading dayJohnson & Johnson stock outperforms market on strong trading day
finance.yahoo.com - July 30 at 5:03 PM
How Much Will Coronavirus Hurt Merck's (MRK) Q2 Earnings? (Revised)How Much Will Coronavirus Hurt Merck's (MRK) Q2 Earnings? (Revised)
finance.yahoo.com - July 30 at 6:58 AM
Merck Announces Two US Regulatory Milestones for KEYTRUDA® (pembrolizumab) in Triple-Negative Breast Cancer (TNBC)Merck Announces Two US Regulatory Milestones for KEYTRUDA® (pembrolizumab) in Triple-Negative Breast Cancer (TNBC)
finance.yahoo.com - July 30 at 6:58 AM
Merck & Co., Inc. (NYSE:MRK) Plans Quarterly Dividend of $0.61Merck & Co., Inc. (NYSE:MRK) Plans Quarterly Dividend of $0.61
www.americanbankingnews.com - July 29 at 7:52 PM
FDA Grants Breakthrough Therapy Designation to Merck’s Novel HIF-2α Inhibitor MK-6482 for Treatment of Certain Patients With Von Hippel-Lindau Disease- Associated Renal Cell CarcinomaFDA Grants Breakthrough Therapy Designation to Merck’s Novel HIF-2α Inhibitor MK-6482 for Treatment of Certain Patients With Von Hippel-Lindau Disease- Associated Renal Cell Carcinoma
finance.yahoo.com - July 29 at 7:47 AM
How Much Will Coronavirus Hurt Merck's (MRK) Q2 Earnings?How Much Will Coronavirus Hurt Merck's (MRK) Q2 Earnings?
finance.yahoo.com - July 28 at 1:53 PM
US Indexes Close Higher Monday After 2-Day SelloffUS Indexes Close Higher Monday After 2-Day Selloff
finance.yahoo.com - July 27 at 7:24 PM
Merck & Co., Inc. (MRK) Scheduled to Post Earnings on FridayMerck & Co., Inc. (MRK) Scheduled to Post Earnings on Friday
www.americanbankingnews.com - July 24 at 1:04 AM
IRBM to collaborate with MSD to develop peptides against coronavirusIRBM to collaborate with MSD to develop peptides against coronavirus
feeds.benzinga.com - July 21 at 3:33 AM
Analyst Sees 60% Upside for Nabriva (NBRV) Following  Merck DealAnalyst Sees 60% Upside for Nabriva (NBRV) Following Merck Deal
finance.yahoo.com - July 17 at 1:11 PM
Merck's NDA for Heart Failure Candidate Gets Priority ReviewMerck's NDA for Heart Failure Candidate Gets Priority Review
finance.yahoo.com - July 17 at 1:11 PM
Merck & Co., Inc. (NYSE:MRK) Expected to Announce Quarterly Sales of $10.84 BillionMerck & Co., Inc. (NYSE:MRK) Expected to Announce Quarterly Sales of $10.84 Billion
www.americanbankingnews.com - July 17 at 3:16 AM
 Brokerages Expect Merck & Co., Inc. (NYSE:MRK) to Post $1.12 Earnings Per Share Brokerages Expect Merck & Co., Inc. (NYSE:MRK) to Post $1.12 Earnings Per Share
www.americanbankingnews.com - July 16 at 4:43 AM
Merck CEO says raising COVID-19 vaccine hopes 'a grave disservice' -reportMerck CEO says raising COVID-19 vaccine hopes 'a grave disservice' -report
finance.yahoo.com - July 14 at 8:00 PM
McDonald's, Dow Inc. share gains lead Dow's nearly 75-point climbMcDonald's, Dow Inc. share gains lead Dow's nearly 75-point climb
finance.yahoo.com - July 14 at 9:59 AM
Roche Forecasted to Be Top Drug Seller in 2026Roche Forecasted to Be Top Drug Seller in 2026
finance.yahoo.com - July 13 at 6:38 PM
Merck's Keytruda Gets Priority Review for Lymphoma IndicationMerck's Keytruda Gets Priority Review for Lymphoma Indication
finance.yahoo.com - July 10 at 2:18 PM
Merck Animal Health Receives U.S. FDA Approval of BRAVECTO® (fluralaner) Monthly ChewsMerck Animal Health Receives U.S. FDA Approval of BRAVECTO® (fluralaner) Monthly Chews
finance.yahoo.com - July 9 at 6:53 PM
Merck Announces Appointment of Organon & Co. General CounselMerck Announces Appointment of Organon & Co. General Counsel
finance.yahoo.com - July 8 at 7:12 PM
Merck and Eisai Receive Complete Response Letter for KEYTRUDA® (pembrolizumab) plus LENVIMA® (lenvatinib) Combination as First-Line Treatment for Unresectable Hepatocellular CarcinomaMerck and Eisai Receive Complete Response Letter for KEYTRUDA® (pembrolizumab) plus LENVIMA® (lenvatinib) Combination as First-Line Treatment for Unresectable Hepatocellular Carcinoma
finance.yahoo.com - July 8 at 9:09 AM
LYNPARZA® (olaparib) Approved in the EU for Germline BRCA-mutated Metastatic Pancreatic CancerLYNPARZA® (olaparib) Approved in the EU for Germline BRCA-mutated Metastatic Pancreatic Cancer
finance.yahoo.com - July 8 at 9:09 AM
FDA declines to approve Merck and Eisai's liver cancer combo therapyFDA declines to approve Merck and Eisai's liver cancer combo therapy
finance.yahoo.com - July 8 at 9:09 AM
Merck, Eisai to put experimental cancer combination in new clinical trialMerck, Eisai to put experimental cancer combination in new clinical trial
finance.yahoo.com - July 8 at 9:09 AM
Merck (MRK) Stock Moves -1.08%: What You Should KnowMerck (MRK) Stock Moves -1.08%: What You Should Know
finance.yahoo.com - July 7 at 7:00 PM
Four clues to the quality of Merck amp; Co Inc (NYQ:MRK)Four clues to the quality of Merck amp; Co Inc (NYQ:MRK)
uk.finance.yahoo.com - July 6 at 8:53 AM
How Many Merck & Co., Inc. (NYSE:MRK) Shares Do Institutions Own?How Many Merck & Co., Inc. (NYSE:MRK) Shares Do Institutions Own?
finance.yahoo.com - July 3 at 1:59 PM
Why the Earnings Surprise Streak Could Continue for Merck (MRK)Why the Earnings Surprise Streak Could Continue for Merck (MRK)
finance.yahoo.com - July 2 at 1:04 PM
Merck to Hold Second-Quarter 2020 Sales and Earnings Conference Call on July 31Merck to Hold Second-Quarter 2020 Sales and Earnings Conference Call on July 31
finance.yahoo.com - July 1 at 9:41 AM
Merck (MRK) Gains But Lags Market: What You Should KnowMerck (MRK) Gains But Lags Market: What You Should Know
finance.yahoo.com - June 29 at 7:42 PM
This page was last updated on 8/10/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.